Filing Flows › Selectis Health (GBCS) › Q3 2025
Selectis Health (GBCS) Q3 2025 earnings results (third quarter 2025)
10-Q filed Nov 14, 2025
Selectis Health (GBCS) reported revenue of $10.8M for the third quarter 2025 (Q3 2025), +8% from a year earlier and +4% from the quarter before. Operating margin was -2.7%, net earnings $752K (6.9% of revenue).
Selectis Health, Q3 2025: revenue $10.8M (+8% year over year), operating margin -2.7%, net earnings $752K, operating cash flow $280K. The chart follows the revenue to costs, profit and cash.
| Q3 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $10.8M | +4% | +8% |
| Operating profit | −$297K | — | — |
| Net earnings | $752K | — | — |
| Operating cash flow | $280K | — | — |
| Free cash flow | $276K | — | — |
What changed
Revenue was $10.8M in Q3 2025, up 8% year over year and up 4% from the previous quarter.
Operating costs exceeded revenue by $297K, an operating margin of -2.7%. Total costs fell 0% while revenue rose 8%. Net earnings were $752K. The effective tax rate was 0.0%. Non-operating items added $1.0M, 139% of pre-tax earnings, so the bottom line overstates operating performance.
Operating cash flow was $280K, 37% of net earnings. Non-cash charges added back $365K of depreciation. Working capital and other items used $837K. Capital expenditures of $4K left free cash flow of $276K.
Questions
What was Selectis Health's revenue in the third quarter 2025?
Selectis Health (GBCS) reported revenue of $10.8M for the third quarter 2025 (Q3 2025), +8% from a year earlier and +4% from the quarter before.
Was Selectis Health profitable in the third quarter 2025?
Operating loss was $297K (-2.7% of revenue) and net earnings $752K.
Source: Selectis Health 10-Q on SEC EDGAR.